Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration
Source: SeekingAlpha
2026-02-24 01:28:45 ET
Editor's note: Seeking Alpha is proud to welcome Mosiv Capital as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » ...
Read the full article on Seeking Alpha
For further details see:
Pliant Therapeutics: A Reverse Arbitrage Opportunity Driven By A Poison Pill Expiration
Pliant Therapeutics Inc.
NASDAQ: PLRX
PLRX Trading
-3.93% G/L:
$1.345 Last:
47,187 Volume:
$1.37 Open:
PLRX Latest News
February 23, 2026 08:00:00 am
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
PLRX Stock Data
$72,817,521
56,533,434
3.63%
28
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
